Advances in fatty acid metabolism reprogramming of lung cancer

Jing WU; Juan ZHOU; Chunxia SU

doi:10.19401/j.cnki.1007-3639.2023.05.012

您当前的位置：

首页 >

文章列表页 >

Advances in fatty acid metabolism reprogramming of lung cancer

Review | 更新时间：2025-12-31

- Advances in fatty acid metabolism reprogramming of lung cancer
- China Oncology Vol. 33, Issue 5, Pages: 517-526(2023)
- 作者机构：
  
  同济大学附属上海市肺科医院肿瘤科，上海 200433
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2023.05.012
  CLC： R734.2
- Received：21 June 2022，
  
  Revised：2022-09-05，
  
  Published：30 May 2023
- 稿件说明：
移动端阅览
Jing WU, Juan ZHOU, Chunxia SU. Advances in fatty acid metabolism reprogramming of lung cancer[J]. China Oncology, 2023, 33(5): 517-526.
DOI：

Jing WU, Juan ZHOU, Chunxia SU. Advances in fatty acid metabolism reprogramming of lung cancer[J]. China Oncology, 2023, 33(5): 517-526. DOI： 10.19401/j.cnki.1007-3639.2023.05.012.

摘要

肺癌是最常见的恶性肿瘤，也是癌症死亡的主要原因。尽管靶向治疗和免疫治疗的发展显著改善了肺癌患者的疗效和预后，但总体5年生存率仍不到20%。因此，深入探索肺癌的发生、发展机制对于确立新的诊疗策略，进一步提高患者生存率具有重要的临床意义。代谢重编程是肿瘤维持恶性生物学行为的重要方式，既往研究表明，脂肪酸代谢重编程在肺癌的发生、发展过程中发挥重要作用，提示靶向肺癌脂肪酸代谢可能是新型抗肿瘤方案研发的重要方向。本文聚焦肺癌脂肪酸代谢重编程，拟从参与脂肪酸代谢包括摄取、合成、储存和分解等各环节的关键蛋白分子出发，综述脂肪酸代谢变化与肺癌发生、发展的关系，并对靶向脂肪酸代谢抗肿瘤治疗的应用现状及面临的挑战进行探讨，以期为确立新的肺癌治疗策略提供线索和参考。

Abstract

Lung cancer is the most common malignant tumor and the leading cause of cancer-related mortality. Although the development of targeted therapy and immunotherapy has significantly improved the efficacy and prognosis of lung cancer patients

the overall 5-year survival rate is still lower than 20%. Therefore

in-depth exploration of the pathogenesis of lung cancer has important clinical significance for the development of new diagnosis and treatment strategies and further improvement of patient survival. Metabolic reprogramming is a crucial way for tumors to maintain malignant biological behavior. Previous studies have shown that fatty acid metabolism reprogramming has profound effects on tumorigenesis and progression of lung cancer

suggesting that targeting lung cancer fatty acid metabolism might be an important direction for the development of new anti-tumor regimens. This paper

focusing on the reprogramming of fatty acid metabolism

reviewed the relationship between fatty acid metabolism and lung cancer progression from the aspects of the key protein molecules involved in each procedure of fatty acid metabolism (including uptake

synthesis

storage and decomposition)

and discussed the application status and challenges of anti-tumor therapy targeting fatty acid metabolism

expecting to provide clues and insights for the development of novel treatment regimen for lung cancer.

关键词

Keywords

references

THAI A A , SOLOMON B J , SEQUIST L V , et al . Lung cancer [J ] . Lancet , 2021 , 398 ( 10299 ): 535 - 554 . DOI: 10.1016/S0140-6736(21)00312-3 http://doi.org/10.1016/S0140-6736(21)00312-3

SIEGEL R L , MILLER K D , FUCHS H E , et al . Cancer statistics, 2022 [J ] . CA Cancer J Clin , 2022 , 72 ( 1 ): 7 - 33 . DOI: 10.3322/caac.v72.1 http://doi.org/10.3322/caac.v72.1 https://onlinelibrary.wiley.com/toc/15424863/72/1 https://onlinelibrary.wiley.com/toc/15424863/72/1

CONWAY E M , PIKOR L A , KUNG S H Y , et al . Macrophages, inflammation, and lung cancer [J ] . Am J Respir Crit Care Med , 2016 , 193 ( 2 ): 116 - 130 . DOI: 10.1164/rccm.201508-1545CI http://doi.org/10.1164/rccm.201508-1545CI https://www.atsjournals.org/doi/10.1164/rccm.201508-1545CI https://www.atsjournals.org/doi/10.1164/rccm.201508-1545CI

HANAHAN D , WEINBERG R A . Hallmarks of cancer: the next generation [J ] . Cell , 2011 , 144 ( 5 ): 646 - 674 . DOI: 10.1016/j.cell.2011.02.013 http://doi.org/10.1016/j.cell.2011.02.013

WARBURG O . On the origin of cancer cells [J ] . Science , 1956 , 123 ( 3191 ): 309 - 314 . DOI: 10.1126/science.123.3191.309 http://doi.org/10.1126/science.123.3191.309

KUMAGAI S , KOYAMA S , ITAHASHI K , et al . Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments [J ] . Cancer Cell , 2022 , 40 ( 2 ): 201 - 218 .e9. DOI: 10.1016/j.ccell.2022.01.001 http://doi.org/10.1016/j.ccell.2022.01.001 https://linkinghub.elsevier.com/retrieve/pii/S1535610822000034 https://linkinghub.elsevier.com/retrieve/pii/S1535610822000034

ALI A , LEVANTINI E , TEO J T , et al . Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer [J ] . EMBO Mol Med , 2018 , 10 ( 3 ): e8313.

CONTAT C , ANCEY P B , ZANGGER N , et al . Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth [J ] . Elife , 2020 , 9 : e53618.

BROADFIELD L A , PANE A A , TALEBI A , et al . Lipid metabolism in cancer: new perspectives and emerging mechanisms [J ] . Dev Cell , 2021 , 56 ( 10 ): 1363 - 1393 . DOI: 10.1016/j.devcel.2021.04.013 http://doi.org/10.1016/j.devcel.2021.04.013

SNAEBJORNSSON M T , JANAKI-RAMAN S , SCHULZE A . Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer [J ] . Cell Metab , 2020 , 31 ( 1 ): 62 - 76 . DOI: S1550-4131(19)30617-5 http://doi.org/S1550-4131(19)30617-5

BENSAAD K , FAVARO E , LEWIS C A , et al . Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation [J ] . Cell Rep , 2014 , 9 ( 1 ): 349 - 365 . DOI: S2211-1247(14)00732-3 http://doi.org/S2211-1247(14)00732-3

CORBET C , BASTIEN E , SANTIAGO DE JESUS J P , et al . TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells [J ] . Nat Commun , 2020 , 11 ( 1 ): 454 . DOI: 10.1038/s41467-019-14262-3 http://doi.org/10.1038/s41467-019-14262-3

ABUMRAD N A , CABODEVILLA A G , SAMOVSKI D , et al . Endothelial cell receptors in tissue lipid uptake and metabolism [J ] . Circ Res , 2021 , 128 ( 3 ): 433 - 450 . DOI: 10.1161/CIRCRESAHA.120.318003 http://doi.org/10.1161/CIRCRESAHA.120.318003

WANG J C , LI Y S . CD36 tango in cancer: signaling pathways and functions [J ] . Theranostics , 2019 , 9 ( 17 ): 4893 - 4908 . DOI: 10.7150/thno.36037 http://doi.org/10.7150/thno.36037

PASCUAL G , AVGUSTINOVA A , MEJETTA S , et al . Targeting metastasis-initiating cells through the fatty acid receptor CD36 [J ] . Nature , 2017 , 541 ( 7635 ): 41 - 45 . DOI: 10.1038/nature20791 http://doi.org/10.1038/nature20791

FENG W W , WILKINS O , BANG S , et al . CD36-mediated metabolic rewiring of breast cancer cells promotes resistance to HER2-targeted therapies [J ] . Cell Rep , 2019 , 29 ( 11 ): 3405 - 3420 .e5. DOI: S2211-1247(19)31479-2 http://doi.org/S2211-1247(19)31479-2

NI K W , WANG D M , XU H Y , et al . miR-21 promotes non-small cell lung cancer cells growth by regulating fatty acid metabolism [J ] . Cancer Cell Int , 2019 , 19 : 219 . DOI: 10.1186/s12935-019-0941-8 http://doi.org/10.1186/s12935-019-0941-8

SUN Q , ZHANG W , WANG L , et al . Hypermethylated CD36 gene affected the progression of lung cancer [J ] . Gene , 2018 , 678 : 395 - 406 . DOI: S0378-1119(18)30764-9 http://doi.org/S0378-1119(18)30764-9

MA X Z , XIAO L L , LIU L T , et al . CD36-mediated ferroptosis dampens intratumoral CD8 + T cell effector function and impairs their antitumor ability [J ] . Cell Metab , 2021 , 33 ( 5 ): 1001 - 1012 .e5. DOI: 10.1016/j.cmet.2021.02.015 http://doi.org/10.1016/j.cmet.2021.02.015 https://linkinghub.elsevier.com/retrieve/pii/S1550413121000711 https://linkinghub.elsevier.com/retrieve/pii/S1550413121000711

WANG H P , FRANCO F , TSUI Y C , et al . CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors [J ] . Nat Immunol , 2020 , 21 ( 3 ): 298 - 308 . DOI: 10.1038/s41590-019-0589-5 http://doi.org/10.1038/s41590-019-0589-5

FHU C W , ALI A . Fatty acid synthase: an emerging target in cancer [J ] . Molecules , 2020 , 25 ( 17 ): 3935 . DOI: 10.3390/molecules25173935 http://doi.org/10.3390/molecules25173935 https://www.mdpi.com/1420-3049/25/17/3935 https://www.mdpi.com/1420-3049/25/17/3935

NIEMAN K M , KENNY H A , PENICKA C V , et al . Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth [J ] . Nat Med , 2011 , 17 ( 11 ): 1498 - 1503 . DOI: 10.1038/nm.2492 http://doi.org/10.1038/nm.2492

刘倩 , 王世凤 , 徐缓 , 等 . CRABPII和E-FABP在非小细胞肺癌中的表达及其意义 [J ] . 中国肺癌杂志 , 2013 , 16 ( 1 ): 12 - 19 .

LIU Q , WANG S F , XU H , et al . Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer [J ] . Chin J Lung Cancer , 2013 , 16 ( 1 ): 12 - 19 .

YANG S H , KOBAYASHI S , SEKINO K , et al . Fatty acid-binding protein 5 controls lung tumor metastasis by regulating the maturation of natural killer cells in the lung [J ] . FEBS Lett , 2021 , 595 ( 13 ): 1797 - 1805 . DOI: 10.1002/1873-3468.14106 http://doi.org/10.1002/1873-3468.14106

KIMURA I , ICHIMURA A , OHUE-KITANO R , et al . Free fatty acid receptors in health and disease [J ] . Physiol Rev , 2020 , 100 ( 1 ): 171 - 210 . DOI: 10.1152/physrev.00041.2018 http://doi.org/10.1152/physrev.00041.2018

WANG X , HE S B , GU Y T , et al . Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis [J ] . EBioMedicine , 2019 , 40 : 251 - 262 . DOI: S2352-3964(18)30614-5 http://doi.org/S2352-3964(18)30614-5

LIU Z , HOPKINS M M , ZHANG Z H , et al . Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells [J ] . J Pharmacol Exp Ther , 2015 , 352 ( 2 ): 380 - 394 . DOI: 10.1124/jpet.114.218974 http://doi.org/10.1124/jpet.114.218974

BARTOSZEK A , FICHNA J , TARASIUK A , et al . Free fatty acid receptors as new potential targets in colorectal cancer [J ] . Curr Drug Targets , 2020 , 21 ( 14 ): 1397 - 1404 . DOI: 10.2174/1389450120666191112141901 http://doi.org/10.2174/1389450120666191112141901 https://www.eurekaselect.com/176603/article https://www.eurekaselect.com/176603/article

MUNKARAH A , MERT I , CHHINA J , et al . Targeting of free fatty acid receptor 1 in EOC: a novel strategy to restrict the adipocyte-EOC dependence [J ] . Gynecol Oncol , 2016 , 141 ( 1 ): 72 - 79 . DOI: 10.1016/j.ygyno.2016.02.026 http://doi.org/10.1016/j.ygyno.2016.02.026

BACCI M , LORITO N , SMIRIGLIA A , et al . Fat and furious: lipid metabolism in antitumoral therapy response and resistance [J ] . Trends Cancer , 2021 , 7 ( 3 ): 198 - 213 . DOI: 10.1016/j.trecan.2020.10.004 http://doi.org/10.1016/j.trecan.2020.10.004

RÖHRIG F , SCHULZE A . The multifaceted roles of fatty acid synthesis in cancer [J ] . Nat Rev Cancer , 2016 , 16 ( 11 ): 732 - 749 . DOI: 10.1038/nrc.2016.89 http://doi.org/10.1038/nrc.2016.89

MOSSMANN D , PARK S , HALL M N . mTOR signalling and cellular metabolism are mutual determinants in cancer [J ] . Nat Rev Cancer , 2018 , 18 ( 12 ): 744 - 757 . DOI: 10.1038/s41568-018-0074-8 http://doi.org/10.1038/s41568-018-0074-8

WILLIAMS K J , ARGUS J P , ZHU Y , et al . An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity [J ] . Cancer Res , 2013 , 73 ( 9 ): 2850 - 2862 . DOI: 10.1158/0008-5472.CAN-13-0382-T http://doi.org/10.1158/0008-5472.CAN-13-0382-T

EZZEDDINI R , TAGHIKHANI M , SOMI M H , et al . Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma [J ] . Life Sci , 2019 , 224 : 169 - 176 . DOI: S0024-3205(19)30220-6 http://doi.org/S0024-3205(19)30220-6

PETERSON T R , SENGUPTA S S , HARRIS T E , et al . mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway [J ] . Cell , 2011 , 146 ( 3 ): 408 - 420 . DOI: 10.1016/j.cell.2011.06.034 http://doi.org/10.1016/j.cell.2011.06.034

MA L , CHEN Z B , ERDJUMENT-BROMAGE H , et al . Phosphorylation and functional inactivation of TSC2 by ERK implications for tuberous sclerosis and cancer pathogenesis [J ] . Cell , 2005 , 121 ( 2 ): 179 - 193 . DOI: 10.1016/j.cell.2005.02.031 http://doi.org/10.1016/j.cell.2005.02.031

GOUW A M , EBERLIN L S , MARGULIS K , et al . Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma [J ] . Proc Natl Acad Sci USA , 2017 , 114 ( 17 ): 4300 - 4305 . DOI: 10.1073/pnas.1617709114 http://doi.org/10.1073/pnas.1617709114

TALEBI A , DEHAIRS J , RAMBOW F , et al . Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy [J ] . Nat Commun , 2018 , 9 ( 1 ): 2500 . DOI: 10.1038/s41467-018-04664-0 http://doi.org/10.1038/s41467-018-04664-0

DAI M , YANG B K , CHEN J , et al . Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer [J ] . Cancer Lett , 2021 , 513 : 36 - 49 . DOI: 10.1016/j.canlet.2021.04.024 http://doi.org/10.1016/j.canlet.2021.04.024

MIGITA T , NARITA T , NOMURA K , et al . ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer [J ] . Cancer Res , 2008 , 68 ( 20 ): 8547 - 8554 . DOI: 10.1158/0008-5472.CAN-08-1235 http://doi.org/10.1158/0008-5472.CAN-08-1235

CSANADI A , KAYSER C , DONAUER M , et al . Prognostic value of malic enzyme and ATP-citrate lyase in non-small cell lung cancer of the young and the elderly [J ] . PLoS One , 2015 , 10 ( 5 ): e0126357.

GUO W N , MA J Y , YANG Y Q , et al . ATP-citrate lyase epigenetically potentiates oxidative phosphorylation to promote melanoma growth and adaptive resistance to MAPK inhibition [J ] . Clin Cancer Res , 2020 , 26 ( 11 ): 2725 - 2739 . DOI: 10.1158/1078-0432.CCR-19-1359 http://doi.org/10.1158/1078-0432.CCR-19-1359

HAN Q , CHEN C A , YANG W , et al . ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway [J ] . Hepatobiliary Pancreat Dis Int , 2021 , 20 ( 3 ): 251 - 261 . DOI: 10.1016/j.hbpd.2020.05.010 http://doi.org/10.1016/j.hbpd.2020.05.010 https://linkinghub.elsevier.com/retrieve/pii/S1499387220302149 https://linkinghub.elsevier.com/retrieve/pii/S1499387220302149

BIAN X , LIU R , MENG Y , et al . Lipid metabolism and cancer [J ] . J Exp Med , 2021 , 218 ( 1 ): e20201606.

SVENSSON R U , PARKER S J , EICHNER L J , et al . Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung cancer in preclinical models [J ] . Nat Med , 2016 , 22 ( 10 ): 1108 - 1119 . DOI: 10.1038/nm.4181 http://doi.org/10.1038/nm.4181

RIOS GARCIA M , STEINBAUER B , SRIVASTAVA K , et al . Acetyl-CoA carboxylase 1-dependent protein acetylation controls breast cancer metastasis and recurrence [J ] . Cell Metab , 2017 , 26 ( 6 ): 842 - 855 .e5. DOI: S1550-4131(17)30570-3 http://doi.org/S1550-4131(17)30570-3

GU L , ZHU Y H , LIN X , et al . Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis [J ] . Oncogene , 2020 , 39 ( 11 ): 2437 - 2449 . DOI: 10.1038/s41388-020-1156-0 http://doi.org/10.1038/s41388-020-1156-0

BASTOS D C , RIBEIRO C F , AHEARN T , et al . Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss [J ] . J Pathol , 2021 , 253 ( 3 ): 292 - 303 . DOI: 10.1002/path.v253.3 http://doi.org/10.1002/path.v253.3 https://onlinelibrary.wiley.com/toc/10969896/253/3 https://onlinelibrary.wiley.com/toc/10969896/253/3

CHANG L G , FANG S R , CHEN Y B , et al . Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway [J ] . Lipids Health Dis , 2019 , 18 ( 1 ): 118 . DOI: 10.1186/s12944-019-1058-8 http://doi.org/10.1186/s12944-019-1058-8

JIANG L , XIAO L , SUGIURA H , et al . Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition [J ] . Oncogene , 2015 , 34 ( 30 ): 3908 - 3916 . DOI: 10.1038/onc.2014.321 http://doi.org/10.1038/onc.2014.321

LEWIS C A , BRAULT C , PECK B , et al . SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme [J ] . Oncogene , 2015 , 34 ( 40 ): 5128 - 5140 . DOI: 10.1038/onc.2014.439 http://doi.org/10.1038/onc.2014.439

YOUNG R M , ACKERMAN D , QUINN Z L , et al . Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress [J ] . Genes Dev , 2013 , 27 ( 10 ): 1115 - 1131 . DOI: 10.1101/gad.198630.112 http://doi.org/10.1101/gad.198630.112 http://genesdev.cshlp.org/lookup/doi/10.1101/gad.198630.112 http://genesdev.cshlp.org/lookup/doi/10.1101/gad.198630.112

ZHANG J Q , SONG F , ZHAO X J , et al . EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer [J ] . Mol Cancer , 2017 , 16 ( 1 ): 127 . DOI: 10.1186/s12943-017-0704-x http://doi.org/10.1186/s12943-017-0704-x

HUANG Q F , WANG Q G , LI D , et al . Co-administration of 20(S)-protopanaxatriol (g-PPT) and EGFR-TKI overcomes EGFR-TKI resistance by decreasing SCD1 induced lipid accumulation in non-small cell lung cancer [J ] . J Exp Clin Cancer Res , 2019 , 38 ( 1 ): 129 . DOI: 10.1186/s13046-019-1120-4 http://doi.org/10.1186/s13046-019-1120-4

LI Z , LIU H , LUO X . Lipid droplet and its implication in cancer progression [J ] . Am J Cancer Res , 2020 , 10 ( 12 ): 4112 - 4122 .

EL-MASHTOLY S F , YOSEF H K , PETERSEN D , et al . Label-free Raman spectroscopic imaging monitors the integral physiologically relevant drug responses in cancer cells [J ] . Anal Chem , 2015 , 87 ( 14 ): 7297 - 7304 . DOI: 10.1021/acs.analchem.5b01431 http://doi.org/10.1021/acs.analchem.5b01431

ZECHNER R , ZIMMERMANN R , EICHMANN T O , et al . FAT SIGNALS: lipases and lipolysis in lipid metabolism and signaling [J ] . Cell Metab , 2012 , 15 ( 3 ): 279 - 291 . DOI: 10.1016/j.cmet.2011.12.018 http://doi.org/10.1016/j.cmet.2011.12.018 https://linkinghub.elsevier.com/retrieve/pii/S1550413112000186 https://linkinghub.elsevier.com/retrieve/pii/S1550413112000186

PRÜSER J L , RAMER R , WITTIG F , et al . The monoacylglycerol lipase inhibitor JZL184 inhibits lung cancer cell invasion and metastasis via the CB1 cannabinoid receptor [J ] . Mol Cancer Ther , 2021 , 20 ( 5 ): 787 - 802 . DOI: 10.1158/1535-7163.MCT-20-0589 http://doi.org/10.1158/1535-7163.MCT-20-0589

KIENZL M , HASENOEHRL C , MAITZ K , et al . Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancer [J ] . Oncoimmunology , 2021 , 10 ( 1 ): 1965319 . DOI: 10.1080/2162402X.2021.1965319 http://doi.org/10.1080/2162402X.2021.1965319 https://www.tandfonline.com/doi/full/10.1080/2162402X.2021.1965319 https://www.tandfonline.com/doi/full/10.1080/2162402X.2021.1965319

LIU R Y , WANG X , CURTISS C , et al . Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma [J ] . Cell Death Dis , 2018 , 9 ( 2 ): 36 . DOI: 10.1038/s41419-017-0188-z http://doi.org/10.1038/s41419-017-0188-z

MA Y B , TEMKIN S M , HAWKRIDGE A M , et al . Fatty acid oxidation: an emerging facet of metabolic transformation in cancer [J ] . Cancer Lett , 2018 , 435 : 92 - 100 . DOI: S0304-3835(18)30518-4 http://doi.org/S0304-3835(18)30518-4

PADANAD M S , KONSTANTINIDOU G , VENKATESWARAN N , et al . Fatty acid oxidation mediated by acyl-CoA synthetase long chain 3 is required for mutant KRAS lung tumorigenesis [J ] . Cell Rep , 2016 , 16 ( 6 ): 1614 - 1628 . DOI: S2211-1247(16)30895-6 http://doi.org/S2211-1247(16)30895-6

WANG T Y , FAHRMANN J F , LEE H , et al . JAK/STAT3-regulated fatty acid β-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance [J ] . Cell Metab , 2018 , 27 ( 6 ): 1357 . DOI: S1550-4131(18)30302-4 http://doi.org/S1550-4131(18)30302-4

HOY A J , NAGARAJAN S R , BUTLER L M . Tumour fatty acid metabolism in the context of therapy resistance and obesity [J ] . Nat Rev Cancer , 2021 , 21 ( 12 ): 753 - 766 . DOI: 10.1038/s41568-021-00388-4 http://doi.org/10.1038/s41568-021-00388-4

SCHLAEPFER I R , JOSHI M . CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential [J ] . Endocrinology , 2020 , 161 ( 2 ): bqz046 . DOI: 10.1210/endocr/bqz046 http://doi.org/10.1210/endocr/bqz046 https://academic.oup.com/endo/article/doi/10.1210/endocr/bqz046/5695911 https://academic.oup.com/endo/article/doi/10.1210/endocr/bqz046/5695911

WANG Y N , ZENG Z L , LU J H , et al . CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis [J ] . Oncogene , 2018 , 37 ( 46 ): 6025 - 6040 . DOI: 10.1038/s41388-018-0384-z http://doi.org/10.1038/s41388-018-0384-z

贾建博 , 王涛 , 辛向兵 , 等 . CPT1A促进肺癌转移的调控作用 [J ] . 海南医学 , 2019 , 30 ( 1 ): 5 - 8 .

JIA J B , WANG T , XIN X B , et al . Roles of CPT1A promoting lung cancer metastasis [J ] . Hainan Med J , 2019 , 30 ( 1 ): 5 - 8 .

KOUNDOUROS N , POULOGIANNIS G . Reprogramming of fatty acid metabolism in cancer [J ] . Br J Cancer , 2020 , 122 ( 1 ): 4 - 22 . DOI: 10.1038/s41416-019-0650-z http://doi.org/10.1038/s41416-019-0650-z

RELAT J , BLANCAFORT A , OLIVERAS G , et al . Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer [J ] . BMC Cancer , 2012 , 12 : 280 . DOI: 10.1186/1471-2407-12-280 http://doi.org/10.1186/1471-2407-12-280

ZHOU W J , ZHANG J , YAN M K , et al . Orlistat induces ferroptosis-like cell death of lung cancer cells [J ] . Front Med , 2021 , 15 ( 6 ): 922 - 932 . DOI: 10.1007/s11684-020-0804-7 http://doi.org/10.1007/s11684-020-0804-7

BUCKLEY D , DUKE G , HEUER T S , et al . Fatty acid synthase-modern tumor cell biology insights into a classical oncology target [J ] . Pharmacol Ther , 2017 , 177 : 23 - 31 . DOI: 10.1016/j.pharmthera.2017.02.021 http://doi.org/10.1016/j.pharmthera.2017.02.021 https://linkinghub.elsevier.com/retrieve/pii/S0163725817300359 https://linkinghub.elsevier.com/retrieve/pii/S0163725817300359

FALCHOOK G , INFANTE J , ARKENAU H T , et al . First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors [J ] . EClinicalMedicine , 2021 , 34 : 100797 . DOI: 10.1016/j.eclinm.2021.100797 http://doi.org/10.1016/j.eclinm.2021.100797 https://linkinghub.elsevier.com/retrieve/pii/S2589537021000778 https://linkinghub.elsevier.com/retrieve/pii/S2589537021000778

GRANCHI C . ATP citrate lyase (ACLY) inhibitors: an anti-cancer strategy at the crossroads of glucose and lipid metabolism [J ] . Eur J Med Chem , 2018 , 157 : 1276 - 1291 . DOI: S0223-5234(18)30773-6 http://doi.org/S0223-5234(18)30773-6

YANG L , ZHANG F Q , WANG X , et al . A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer [J ] . Oncotarget , 2016 , 7 ( 34 ): 55543 - 55554 . DOI: 10.18632/oncotarget.10837 http://doi.org/10.18632/oncotarget.10837

VENTURA R , MORDEC K , WASZCZUK J , et al . Inhibition of de novo palmitate synthesis by fatty acid synthase induces apoptosis in tumor cells by remodeling cell membranes, inhibiting signaling pathways, and reprogramming gene expression [J ] . EBioMedicine , 2015 , 2 ( 8 ): 808 - 824 . DOI: 10.1016/j.ebiom.2015.06.020 http://doi.org/10.1016/j.ebiom.2015.06.020

LOOMBA R , MOHSENI R , LUCAS K J , et al . TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial [J ] . Gastroenterology , 2021 , 161 ( 5 ): 1475 - 1486 . DOI: 10.1053/j.gastro.2021.07.025 http://doi.org/10.1053/j.gastro.2021.07.025 https://linkinghub.elsevier.com/retrieve/pii/S0016508521032765 https://linkinghub.elsevier.com/retrieve/pii/S0016508521032765

ZHANG C , LIU J , HUANG G , et al . Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression [J ] . Genes Dev , 2016 , 30 ( 17 ): 1956 - 1970 . DOI: 10.1101/gad.283283.116 http://doi.org/10.1101/gad.283283.116 http://genesdev.cshlp.org/lookup/doi/10.1101/gad.283283.116 http://genesdev.cshlp.org/lookup/doi/10.1101/gad.283283.116

HANAI J , DORO N , SASAKI A T , et al . Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase (PI3K)/AKT pathways [J ] . J Cell Physiol , 2012 , 227 ( 4 ): 1709 - 1720 . DOI: 10.1002/jcp.22895 http://doi.org/10.1002/jcp.22895 https://onlinelibrary.wiley.com/doi/10.1002/jcp.22895 https://onlinelibrary.wiley.com/doi/10.1002/jcp.22895

HATZIVASSILIOU G , ZHAO F P , BAUER D E , et al . ATP citrate lyase inhibition can suppress tumor cell growth [J ] . Cancer Cell , 2005 , 8 ( 4 ): 311 - 321 . DOI: 10.1016/j.ccr.2005.09.008 http://doi.org/10.1016/j.ccr.2005.09.008

PISANU M E , NOTO A , DE VITIS C , et al . Blockade of stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells [J ] . Cancer Lett , 2017 , 406 : 93 - 104 . DOI: S0304-3835(17)30463-9 http://doi.org/S0304-3835(17)30463-9

SHE K L , FANG S H , DU W , et al . SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals [J ] . Cancer Cell Int , 2019 , 19 : 103 . DOI: 10.1186/s12935-019-0809-y http://doi.org/10.1186/s12935-019-0809-y

HESS D , CHISHOLM J W , IGAL R A . Inhibition of stearoyl-CoA-desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells [J ] . PLoS One , 2010 , 5 ( 6 ): e11394.

VRIENS K , CHRISTEN S , PARIK S , et al . Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity [J ] . Nature , 2019 , 566 ( 7744 ): 403 - 406 . DOI: 10.1038/s41586-019-0904-1 http://doi.org/10.1038/s41586-019-0904-1

LIEN E C , WESTERMARK A M , ZHANG Y , et al . Low glycaemic diets alter lipid metabolism to influence tumour growth [J ] . Nature , 2021 , 599 ( 7884 ): 302 - 307 . DOI: 10.1038/s41586-021-04049-2 http://doi.org/10.1038/s41586-021-04049-2

DIERGE E , DEBOCK E , GUILBAUD C , et al . Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects [J ] . Cell Metab , 2021 , 33 ( 8 ): 1701 - 1715 .e5. DOI: 10.1016/j.cmet.2021.05.016 http://doi.org/10.1016/j.cmet.2021.05.016

Views

4520

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Recent advances and prospect in targeted therapy for lung cancer

Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients: a case report and literature review

Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives

Research status and progress of third-line treatment for metastatic colorectal cancer

Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

Related Author

洪少东

张　力

LIU Miao

LI Jinze

WU Chensi

ZHANG Fengbin

GAO Hongsheng

ZHANG Ruixing

Related Institution

中山大学肿瘤防治中心内科

Department of Gastroenterology, the Fourth Hospital of Hebei Medical University

Department of Pathology, the Fourth Hospital of Hebei Medical University

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

AI问答

⁰